Portal vein thrombosis in inflammatory bowel diseases: a single-center case series

J Crohns Colitis. 2012 Apr;6(3):362-7. doi: 10.1016/j.crohns.2011.10.003. Epub 2011 Nov 10.

Abstract

Background and methods: Portal vein thrombosis (PVT) has been reported as a complication of IBD in some case reports. We describe the presentation, diagnostic approaches, underlying risks factors and clinical outcome of 8 IBD patients with PVT. CASE-SERIES: The patients presented with partial PVT (4 patients) or portal cavernoma. Five patients had undergone surgery. In 2 patients portal biliopathy was diagnosed after detection of PVT. In 4 patients, the diagnosis of PVT was made while IBD was in remission. Five patients showed at least one risk factor for hypercoagulability: lupus anti-coagulant (one patient), increased von Willebrand factor (2 patients) or homocysteine levels (4 patients). Four patients received anticoagulant therapy for 6 months. None experienced other thrombotic events during a median of 5 years (range 2-8 years).

Conclusion: PVT is a potential complication of IBD, usually associated with acquired or inherited risks factors for hypercoagulability and with a benign outcome.

MeSH terms

  • Adult
  • Anticoagulants / therapeutic use
  • Colitis, Ulcerative / complications*
  • Crohn Disease / complications*
  • Female
  • Homocysteine / blood
  • Humans
  • Lupus Coagulation Inhibitor / blood
  • Male
  • Middle Aged
  • Portal Vein*
  • Retrospective Studies
  • Risk Factors
  • Thrombophilia / blood
  • Thrombophilia / complications
  • Thrombophilia / genetics
  • Venous Thrombosis / blood
  • Venous Thrombosis / complications*
  • Venous Thrombosis / drug therapy
  • von Willebrand Factor / metabolism

Substances

  • Anticoagulants
  • Lupus Coagulation Inhibitor
  • von Willebrand Factor
  • Homocysteine